MiNK Therapeutics Presents New Preclinical and Clinical Data on iNKT Cell Therapy Programs at SITC 2021

NEXT STORY
Immunocore presents new data on tebentafusp in metastatic cutaneous melanoma (mCM) and uveal melanoma (mUM) at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting
PREV STORY
The Worldwide Biosimilars Industry is Expected to Reach $44.7 Billion by 2026
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Generex Biotechnology Announces Postponement of Its May 15th Investor Conference Call

author_avatar
NASDAQ Market News

Rehabilitation Robots Market to Witness an Impressive CAGR of 22.1%; Strategic Investments by Key Market Players to Propel Market, says Fortune Business Insights

author_avatar
NASDAQ Market News

Paratek’s New Drug Applications for Oral and Intravenous Omadacycline Accepted for Priority Review by FDA

author_avatar
NASDAQ Market News